Literature DB >> 2828241

Regulation of IgE-dependent antiparasite functions of rat macrophages and platelets by nedocromil sodium.

T Thorel1, M Joseph, H Vorng, A Capron.   

Abstract

The IgE-dependent stimulation of mononuclear phagocytes and blood platelets can be measured by antiparasite cytotoxicity, oxygen-mediated chemiluminescence and, in macrophages, lysosomal enzyme activity. Using these parameters, the present study demonstrated an inhibition by nedocromil sodium of the IgE-mediated triggering of the nonmast cell inflammatory populations in the rat. These observations suggest that nedocromil sodium may be of value in the modulation of IgE-dependent cell activation inducing the release of inflammatory mediators.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2828241     DOI: 10.1159/000234507

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  5 in total

1.  The abnormal in vitro response to aspirin of platelets from aspirin-sensitive asthmatics is inhibited after inhalation of nedocromil sodium but not of sodium cromoglycate.

Authors:  C H Marquette; M Joseph; A B Tonnel; H Vorng; P Lassalle; A Tsicopoulos; A Capron
Journal:  Br J Clin Pharmacol       Date:  1990-05       Impact factor: 4.335

2.  Effect of nedocromil sodium on the beta-adrenergic response of human polymorphonuclear leucocytes.

Authors:  W W Busse; B Randlev; M Arbabian; A Ruoho
Journal:  Drugs       Date:  1989       Impact factor: 9.546

3.  A placebo-controlled blinded comparison of nedocromil sodium and beclomethasone dipropionate in bronchial asthma.

Authors:  K C Bergmann; C P Bauer; A Overlack
Journal:  Lung       Date:  1990       Impact factor: 2.584

4.  Nedocromil sodium inhibition of IgE-mediated activation of human mononuclear phagocytes and platelets from asthmatics.

Authors:  M Joseph; T Thorel; A Tsicopoulos; A B Tonnel; A Capron
Journal:  Drugs       Date:  1989       Impact factor: 9.546

Review 5.  Nedocromil sodium. An updated review of its pharmacological properties and therapeutic efficacy in asthma.

Authors:  R N Brogden; E M Sorkin
Journal:  Drugs       Date:  1993-05       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.